期刊文献+

磁性热敏阿霉素脂质体聚集及释药特性的体外观察 被引量:3

Observation of adriamycin assembly and release in vitro using magnetic thermosensitive liposomes
下载PDF
导出
摘要 目的:探讨磁场和加热作用下磁性热敏阿霉素脂质体在体外的聚集及释药情况。方法:实验按水浴加热温度分为6组,分别为21、33、39、42和45℃组以及对照组,同时每一组又分为施加磁场组与未施加磁场组2个亚组。利用LY荧光标记阿霉素后,制备成磁性热敏阿霉素脂质体。采用外加磁场定位对磁性热敏阿霉素脂质体进行聚集引导,水浴加热使其释放阿霉素,通过荧光分析仪观察其聚集、释放药物及与腺癌细胞(腺癌细胞株HT-29)结合情况。结果:在体外强磁场作用下磁性热敏阿霉素脂质体出现定向聚集,在水浴加热至33℃时阿霉素开始释放,并可与腺癌细胞结合,42℃时药物释放量可达到90%以上。其中21、33和39℃时释放药物与腺瘤细胞结合率均低于对照组(P<0.01),在39、42和45℃药物释放率施加磁场亚组与未施加磁场亚组比较差异有显著性(P<0.01)。结论:磁场可以明显提高磁性热敏阿霉素脂质体的体外定向聚集性,温度可以控制磁性热敏阿霉素脂质体对阿霉素的释放及其与腺癌细胞的结合。 Objective To study the assembly and release of adriamycin in vitro using magnetic thermosensitive liposomes treated with magnetic field and pyrogenation. Methods All samples were divided into six groups : 21, 33, 39, 42, 45℃ and control groups according to the temperature of water bath. Lucifer yellow iodoacetamide (LY) was used as a fluorescence marker to adriamycin which was encapsulated by magnetic thermosensitive liposomes. Liposomes was localized under the action of magnetic field, and adriamycin was released through the use of water baths with LY used as a fluorescence marker to observe the assembly and release. Temperature-treated liposomes were mixed with CT-26 cells to measure the binding of the released LY-marked adriamycin to cell surface. Results The magnetic thermosensitive adriamycin liposomes was assembled directionally under magnetic field. The onset of LY release occurred near 33℃, and reached plateau above 42℃ when 90% of the LY was released. The binding with the HT-29 had positive correlation with the release of the LY-marked adriamycin. Conclusion Magnetic field can make the magnetic thermosensitive liposomes drug to assemble directionally, hyperthermia can control the release of drug from magnetic thermosensitive liposomes.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2007年第1期71-74,共4页 Journal of Jilin University:Medicine Edition
基金 全军"十一五"医药卫生面上项目资助课题(06MA208) 西安市科技攻关项目资助课题(GG050167)
关键词 脂质体 阿霉素 热敏 磁性 liposome adriamycin thermosensitive magnetic
  • 相关文献

参考文献10

  • 1Wells J, Sen A, Sek WH. Localized delivery to CT 26 tumors in mice using thermosensitive liposomes[J]. Int J Pharm,2003, 261 (1-2) : 105-114.
  • 2Kullberg M, Mann K, Owens JL. Improved drug delivery tocancer cells: a method using magnetoliposomes that target epidermal growth factor receptors Molecular mechanism of the lipid vesicle longevity in vlvo [J]. Med Hypotheses, 2005,64 (3): 468-470.
  • 3吴道澄,马保安,万明习,范清宇.MDP-阿霉素脂质体交联物治疗大鼠成骨肉瘤的药效学研究[J].中国现代应用药学,2002,19(6):435-437. 被引量:3
  • 4Chandaroy P, Sen A, Hui SW. Temperature-controlled content release from liposomes encapsulating Pluronic F127[J]. J Control Release, 2001, 11, 76 (1-2): 27-37.
  • 5刘同刚,唐敏章,金发光.加温敏感阿霉素脂质体治疗小鼠荷Lewis肺癌[J].第四军医大学学报,2003,24(4):335-337. 被引量:11
  • 6Andresen TL, Jensen SS, Jorgensen K. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release Progress in Lipid Resarch[J].Prog Lipid Res, 2005, 44 (1): 68-97.
  • 7Ickenstein LM, Arfvidsson MC, Needham D, et al. Disc formation in cholesterol free liposomes during phase transition[J]. Biochim Biophys Acta, 2003 , 1614 (2):135-138.
  • 8Kong G, Anyarambhatla G, Petros WP, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model, importance of triggered drug release [J]. Cancer Res,2000 , 60 (24): 6950-6957.
  • 9Castile JD, Taylor KM, Buckton G. The influence of incubation temperature and surfactant concentration on the interaction between dimyristoylphosphatidylcholine liposomes and poloxamer surfactants [J ]. Int J Pharm, 2001,221 (1-2): 197-209.
  • 10怀淑君,王杨,冯三吉.热疗联合胸腔灌注顺铂治疗恶性胸水临床观察[J].吉林大学学报(医学版),2003,29(3):357-358. 被引量:4

二级参考文献18

  • 1鄂征.组织培养技术[M].北京:人民卫生出版社,1993.185-189.
  • 2周茜菁 方青芳.[A]..顺铂胸腔灌注联合热疗治疗癌性胸水的临床观察[C].全国第八届肿瘤热疗会议,2000.119.
  • 3周茜菁 方青芳.顺铂胸腔灌注联合热疗治疗癌性胸水的临床观察[A]..全国第八届肿瘤热疗会议[C].,2000.119.
  • 4[1]Shimose S, Sugita T, Nitta Y, Kubo T, Ikuta Y, Murakami T. Effect of thermosensitive liposomal doxorubicin with hyperthermia on primary tumor and lung metastases in hamster osteosarcoma [J]. Int J Oncol,2001;19(3): 585-589.
  • 5[2]Nakao K, Otsuki Y, Akao Y, Ito Y, Marukawa O, Tachibana S, Kawakami M, Sasaki S. The synergistic effects of hyperthermia and anticancer drugs on induction of apoptosis [J]. Med Electron Microsc,2000;33(1): 44-50.
  • 6[3]Pacher P, Liaudet L, Bai P, Virag L, Mabley JG, Hasko G, Szabo C. Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure [J]. J Pharmacol Exp Ther, 2002;300(3): 862-867.
  • 7[4]Mihm MJ, Yu F, Weinstein DM, Reiser PJ, Bauer JA. Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: Evidence for selective impairment of myofibrillar creatine kinase [J]. Br J Pharmacol, 2002;135(3): 581-588.
  • 8[5]Safra T, Muggia F, Jeffers S, Tsao-wei DD, Groshen S, Lyass O, Henderson R, Berry G, Gabizon A. Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg·m-2 [J]. Ann Oncol, 2000;11(8): 1029-1033.
  • 9[6]Batist G, Ramakrishnan G, Rao CS, Chandrasekharan A, Gutheil J, Guthrie T, Shah P, Khojasteh A, Nair MK, Hoelzer K, Tkaczuk K, Park YC, Lee LW. Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer [J]. J Clin Oncol, 2001;19(5): 1444-1454.
  • 10Dorr RT., Von Hoff DD. Cance Chemotherapy Handbook. 2nd.出版地:Appleton and Norwalk,1994,284.

共引文献15

同被引文献72

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部